Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cebranopadol in Painful Diabetic Polyneuropathy
NCT00878293Phase 2Completed
- Sponsor
- Tris Pharma
- Start
- Apr 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of cebranopadol in diabetic polyneuropathy (DPN), sponsored by Tris Pharma. Started Apr 2009; status: completed.
02
Drugs
cebranopadol
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT00878293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00878293.